BioMarin Pharmaceutical (BMRN) News Today $71.24 -0.36 (-0.50%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$71.18 -0.06 (-0.08%) As of 03/21/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Blueshift Asset Management LLC Invests $349,000 in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Blueshift Asset Management LLC purchased a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 5,314 shares of the biotechnology company's stMarch 23 at 5:13 AM | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Purchased by Sector Gamma ASSector Gamma AS grew its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 14.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 217,348 shares of the biotechnolMarch 22 at 6:51 AM | marketbeat.comHighTower Advisors LLC Acquires 10,730 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)HighTower Advisors LLC lifted its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 34.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 41,468 shares of the biotechnology company'sMarch 22 at 3:36 AM | marketbeat.comProficio Capital Partners LLC Makes New $920,000 Investment in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Proficio Capital Partners LLC bought a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 14,000 shares of the biotechnoMarch 22 at 3:16 AM | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) CAO Sells $92,618.40 in StockBioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Get Free Report) CAO Erin Burkhart sold 1,295 shares of the stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.52, for a total transaction of $92,618.40. Following the completion of the transaction, the chief accounting officer now directly owns 16,955 shares of the company's stock, valued at $1,212,621.60. The trade was a 7.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.March 21 at 10:05 PM | marketbeat.comQ4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN)March 21 at 7:46 AM | msn.comEverSource Wealth Advisors LLC Sells 6,469 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)EverSource Wealth Advisors LLC lowered its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 91.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 634 shares of the biotechnology company's stock afterMarch 21 at 3:44 AM | marketbeat.comBioMarin presents studies showing efficacy of Voxzogo, PalynziqMarch 21 at 1:34 AM | markets.businessinsider.comBioMarin presents studies showing efficacy of Voxzogo, PalynziqMarch 21 at 1:34 AM | markets.businessinsider.comBioMarin Pharmaceutical (BMRN): Among Paul Singer’s Latest Portfolio’s Top Stock PicksMarch 21 at 1:34 AM | msn.comQ4 Rundown: Biogen (NASDAQ:BIIB) Vs Other Therapeutics StocksMarch 20 at 10:34 AM | finance.yahoo.comBioMarin Presents New Data Demonstrating Favorable Safety and Strong Adherence in Real-World Clinical Practice with VOXZOGO® (vosoritide) in Children Under 3 with Achondroplasia at 2025 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics MeetingMarch 20 at 9:00 AM | prnewswire.comIntech Investment Management LLC Has $10.63 Million Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Intech Investment Management LLC increased its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 200.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 161,735 shares of the biotechnology compaMarch 19, 2025 | marketbeat.comBioMarin Pharmaceutical (NASDAQ:BMRN) Rating Increased to Strong-Buy at StockNews.comMarch 19, 2025 | americanbankingnews.com10 strong performing energy and health care stocks as markets resume sell-offMarch 18, 2025 | msn.comIs BioMarin Pharmaceutical (BMRN) the Best Biotech Stock According to Billionaires?March 18, 2025 | insidermonkey.comPrimecap Management Co. CA Decreases Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Primecap Management Co. CA cut its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 3.6% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 18,189,171 shares of the biotechnology company's stock afterMarch 18, 2025 | marketbeat.comBioMarin Pharmaceutical (NASDAQ:BMRN) Upgraded at StockNews.comStockNews.com upgraded shares of BioMarin Pharmaceutical from a "buy" rating to a "strong-buy" rating in a research report on Tuesday.March 18, 2025 | marketbeat.comZacks Research Has Bullish Estimate for BMRN Q1 EarningsMarch 18, 2025 | americanbankingnews.comJ.P. Morgan Remains a Buy on BioMarin Pharmaceutical (BMRN)March 17, 2025 | markets.businessinsider.comPiper Sandler Reaffirms Their Buy Rating on BioMarin Pharmaceutical (BMRN)March 17, 2025 | markets.businessinsider.comLbp Am Sa Sells 11,237 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Lbp Am Sa trimmed its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 67.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,449 shares of the biotechnology company's stock after selling 11March 17, 2025 | marketbeat.comSwiss National Bank Sells 25,800 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Swiss National Bank decreased its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 4.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 537,800 shares of the biotechnology company's stock after sellMarch 17, 2025 | marketbeat.comZacks Research Issues Positive Forecast for BMRN EarningsBioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) - Equities research analysts at Zacks Research lifted their Q1 2025 earnings estimates for shares of BioMarin Pharmaceutical in a research report issued to clients and investors on Wednesday, March 12th. Zacks Research analyst S. Ganoria noMarch 17, 2025 | marketbeat.comErste Asset Management GmbH Lowers Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Erste Asset Management GmbH reduced its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 89.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 69,935 shares of the biotechnologyMarch 16, 2025 | marketbeat.comSkandinaviska Enskilda Banken AB publ Acquires 17,729 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Skandinaviska Enskilda Banken AB publ lifted its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 29.6% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 77,598 shares of the biotechnology company's stock after acquiring an addiMarch 16, 2025 | marketbeat.comWhat is Zacks Research's Estimate for BMRN Q2 Earnings?March 16, 2025 | americanbankingnews.comBioMarin Pharmaceutical (NASDAQ:BMRN) Stock Price Down 1.8% - What's Next?BioMarin Pharmaceutical (NASDAQ:BMRN) Shares Down 1.8% - Should You Sell?March 15, 2025 | marketbeat.comZacks Research Issues Positive Estimate for BMRN EarningsBioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) - Investment analysts at Zacks Research raised their Q2 2026 earnings per share estimates for shares of BioMarin Pharmaceutical in a research note issued to investors on Wednesday, March 12th. Zacks Research analyst S. Ganoria now anticipatMarch 15, 2025 | marketbeat.comTredje AP fonden Has $14.70 Million Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Tredje AP fonden grew its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 662.6% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 223,664 shares of the biotechnology company's stock after buying an additional 194,334 shares during the periMarch 15, 2025 | marketbeat.comDaiwa Securities Group Inc. Raises Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Daiwa Securities Group Inc. raised its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 25.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 22,615 shares of the biotechnology compaMarch 15, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Acquired by PGGM InvestmentsPGGM Investments increased its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 12.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 243,682 shares of the biotechnology coMarch 14, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Has $23.43 Million Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Connor Clark & Lunn Investment Management Ltd. grew its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 206.6% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 356,496 shares of the biotechnology company's stock afteMarch 14, 2025 | marketbeat.comAGF Management Ltd. Sells 1,194,524 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)AGF Management Ltd. reduced its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 96.8% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 39,932 shares of the biotechnology company's stock afterMarch 14, 2025 | marketbeat.comAssetmark Inc. Has $326,000 Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Assetmark Inc. lifted its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 1,391.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,953 shares of the biotechnology company's stock after buying an additiMarch 13, 2025 | marketbeat.comWall Street Analysts Believe BioMarin (BMRN) Could Rally 36.57%: Here's is How to TradeMarch 12, 2025 | msn.comAlphaQuest LLC Raises Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)AlphaQuest LLC raised its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 137.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 10,311 shares of the biotechnologyMarch 12, 2025 | marketbeat.comWinners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics StocksMarch 11, 2025 | msn.comMachina Capital S.A.S. Sells 3,865 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Machina Capital S.A.S. decreased its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 51.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,684 shares of the biotechnology company'sMarch 10, 2025 | marketbeat.comAndra AP fonden Decreases Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Andra AP fonden cut its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 51.7% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 11,200 shares of the biotechnology company's stock after selling 12,000 shaMarch 10, 2025 | marketbeat.comCallan Family Office LLC Invests $491,000 in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Callan Family Office LLC bought a new position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 7,470 shares of the biotechnology company's stock, valued atMarch 10, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Acquires 21,880 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Charles Schwab Investment Management Inc. raised its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 1.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,423,508 shares of the biotechnMarch 10, 2025 | marketbeat.comProficio Capital Partners LLC Takes Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Proficio Capital Partners LLC purchased a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 14,000 shares of the biotechnology compMarch 9, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Acquired by Edgestream Partners L.P.Edgestream Partners L.P. increased its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 407.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 144,996 shares of the biotechnology company's stockMarch 8, 2025 | marketbeat.comCandriam S.C.A. Buys 252,820 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Candriam S.C.A. raised its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 77.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 580,222 shares of the biotechnology company's stock after buying an additiMarch 7, 2025 | marketbeat.com34,019 Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Acquired by Inceptionr LLCInceptionr LLC acquired a new position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 34,019 shares of the biotechnology company's stock, valued at approximately $2,23March 7, 2025 | marketbeat.comBioMarin Pharmaceutical: Strategic Growth and Pipeline Potential Drive Buy RatingMarch 7, 2025 | tipranks.comKeybank National Association OH Lowers Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Keybank National Association OH cut its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 57.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 69,584 shares of the biotechnology company's stock after sMarch 6, 2025 | marketbeat.comBioMarin Pharmaceutical (BMRN) Receives a Buy from TD CowenMarch 5, 2025 | markets.businessinsider.comPlato Investment Management Ltd Acquires 4,334 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)Plato Investment Management Ltd raised its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 85.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,402 shares of the biotMarch 5, 2025 | marketbeat.com Remove Ads Get BioMarin Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for BMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address BMRN Media Mentions By Week BMRN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMRN News Sentiment▼0.960.64▲Average Medical News Sentiment BMRN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMRN Articles This Week▼2810▲BMRN Articles Average Week Remove Ads Get BioMarin Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for BMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ALNY News Today BIIB News Today UTHR News Today INCY News Today NBIX News Today EXEL News Today RGEN News Today EXAS News Today HALO News Today MDGL News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BMRN) was last updated on 3/23/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioMarin Pharmaceutical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioMarin Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BMRN Stock Free BMRN Stock Alerts